APA (7th ed.) Citation

Bedikian, A. Y., Silverman, J. A., Papadopoulos, N. E., Kim, K. B., Hagey, A. E., Vardeleon, A., . . . Hwu, P. (2011). Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function. Journal of clinical pharmacology, 51(8), 1205-1212. https://doi.org/10.1177/0091270010381499

Chicago Style (17th ed.) Citation

Bedikian, Agop Y., et al. "Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function." Journal of Clinical Pharmacology 51, no. 8 (2011): 1205-1212. https://doi.org/10.1177/0091270010381499.

MLA (9th ed.) Citation

Bedikian, Agop Y., et al. "Pharmacokinetics and Safety of Marqibo (Vincristine Sulfate Liposomes Injection) in Cancer Patients With Impaired Liver Function." Journal of Clinical Pharmacology, vol. 51, no. 8, 2011, pp. 1205-1212, https://doi.org/10.1177/0091270010381499.